Volume 84 • 2023 • 2

In Memoriam

Meta-Analysis

Systematic Review

Original Research

JCP
Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder
JCP
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN—A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
JCP
Ten-Year Follow-Up of Earthquake Survivors: Long-Term Study on the Course of PTSD Following a Natural Disaster
JCP
Preventive Health Care Among Children of Women With Schizophrenia: A Population-Based Cohort Study
JCP
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans
JCP
Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up Study
JCP
Opening Doors to Recovery: A Randomized Controlled Trial of a Recovery-Oriented Community Navigation Service for Individuals With Serious Mental Illnesses and Repeated Hospitalizations
JCP
Long-Term Suicidal Ideation Profiles in Late-Life Depression and Their Association With Suicide Attempt or Death by Suicide
JCP
Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study
JCP
Association of Recent and Past Suicide Attempts With Health-Related Quality of Life
JCP
Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia
JCP
Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
JCP
Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

Academic Highlights

Commentary

Clinical and Practical Psychopharmacology

ASCP Corner

Brief Report

Case Report